The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I
Open accessAbstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is often associated with peripheral muscle weakness, which is caused by several factors. Acute exacerbations may contribute, but their impact on muscle force remains unclear. Correlations between peripheral muscle force and inflammatory and anabolic markers have never been studied in COPD. The effect of an acute exacerbation on quadriceps peak torque (QPT) was therefore studied in hospitalised patients, and the aforementioned correlations were examined in hospitalised and in stable patients. METHODS: Lung function, respiratory and peripheral muscle force, and inflammatory and anabolic markers were assessed in hospitalised patients on days 3 and 8 of the hospital admission and 90 days later. The results on day 3 (n=34) were compared with those in clinically stable outpatients (n=13) and sedentary healthy elderly subjects (n=10). RESULTS: Hospitalised patients had lowest mean (SD) QPT (66 (22)% predicted) and highest median (IQR) levels of systemic interleukin-8 (CXCL8, 6.1 (4.5 to 8.3) pg/ml). Insulin-like growth factor I (IGF-I) tended to be higher in healthy elderly subjects (p=0.09). QPT declined between days 3 and 8 in hospital (mean -5% predicted (95% CI -22 to 8)) and partially recovered 90 days after admission to hospital (mean 6% predicted (95% CI -1 to 23)). QPT was negatively correlated with CXCL8 and positively correlated with IGF-I and lung transfer factor in hospitalised and in stable patients. CONCLUSIONS: Peripheral muscle weakness is enhanced during an acute exacerbation of COPD. CXCL8 and IGF-I may be involved in the development of peripheral muscle weakness in hospitalised and in stable patients with COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
(1993) · PubMed · Cited by 3,827
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Grip and pinch strength: normative data for adults.
Mathiowetz, V. G., Kashman, N., Volland, G., Weber, K., Dowe-Keval, M., & Rogers, S. R. (1985) · PubMed · Cited by 2,154
Maximal respiratory pressures: normal values and relationship to age and sex.
Black, L. F., & Hyatt, R. E. (1969) · PubMed · doi:10.1164/arrd.1969.99.5.696 · Cited by 1,877
Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m326 · Cited by 1,294
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
Peripheral muscle weakness contributes to exercise limitation in COPD.
Gosselink, R., Troosters, T., & Decramer, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.3.8630582 · Cited by 1,027
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Peripheral Muscle Weakness in Patients with Chronic Obstructive Pulmonary Disease
BERNARD, S., LeBLANC, P., WHITTOM, F., CARRIER, G., JOBIN, J., BELLEAU, R., & MALTAIS, F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.2.9711023 · Cited by 817
Schols, A. M., Buurman, W. A., Staal van den Brekel, A. J., Dentener, M. A., & Wouters, E. F. (1996) · Thorax · doi:10.1136/thx.51.8.819 · Cited by 522
Li, Y.-P., Schwartz, R. J., Waddell, I. D., Holloway, B. R., & Reid, M. B. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.871 · Cited by 499
Corticosteroids contribute to muscle weakness in chronic airflow obstruction.
Decramer, M., Lacquet, L. M., Fagard, R., & Rogiers, P. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.1.8025735 · Cited by 489
Muscle weakness is related to utilization of health care resources in COPD patients
Decramer, M., Gosselink, R., Troosters, T., Verschueren, M., & Evers, G. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10020417 · Cited by 457
Seemungal, T., MacCallum, P., Paul, E., Donaldson, G., Bhowmik, A., Jeffries, D., Meade, T., & Wedzicha, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613998 · Cited by 447
Characterization of a cancer cachectic factor
Todorov, P., Cariuk, P., McDevitt, T., Coles, B., Fearon, K., & Tisdale, M. (1996) · Nature · doi:10.1038/379739a0 · Cited by 437
Skeletal muscle dysfunction in chronic obstructive pulmonary disease
Jeffery Mador, M., & Bozkanat, E. (2001) · Respiratory Research · doi:10.1186/rr60 · Cited by 425
Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary Disease
EID, A. A., IONESCU, A. A., NIXON, L. S., LEWIS-JENKINS, V., MATTHEWS, S. B., GRIFFITHS, T. L., & SHALE, D. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.8.2008109 · Cited by 376
Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.
Thompson, W. H., Nielson, C. P., Carvalho, P., Charan, N. B., & Crowley, J. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.2.8756814 · Cited by 341
Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients.
de Godoy, I., Donahoe, M., Calhoun, W. J., Mancino, J., & Rogers, R. M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564110 · Cited by 334
Casaburi, R. H., Gosselink, R., Decramer, M., Dekhuijzen, R. P. N., Fournier, M., Lewis, M. I., Maltais, F., Oelberg, D., Reid, M. B., Roca, J., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · Cited by 332
Reid, M. B., Lännergren, J., & Westerblad, H. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2202005 · Cited by 322
Resistance versus endurance training in patients with COPD and peripheral muscle weakness
Spruit, M. A., Gosselink, R., Troosters, T., De Paepe, K., & Decramer, M. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00287102 · Cited by 321
Self-citationAntibiotic therapy in exacerbations of chronic obstructive pulmonary disease
Wagner, K. J. (1987) · The Journal of Emergency Medicine · doi:10.1016/0736-4679(87)90153-3 · Cited by 301
Cook, E. B., Stahl, J. L., Lowe, L., Chen, R., Morgan, E., Wilson, J., Varro, R., Chan, A., Graziano, F. M., & Barney, N. P. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00407-0 · Cited by 285
Decramer, M., de Bock, V, & Dom, R. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665061 · Cited by 281
Influence of training and of inactivity on muscle strength.
MULLER, E. A. (1970) · PubMed · Cited by 280
Association of IGF-I levels with muscle strength and mobility in older women
Cappola, A. R., Bandeen-Roche, K., Wand, G. S., Volpato, S., & Fried, L. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7868 · Cited by 205
Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man
Polkey, M. I., Kyroussis, D., Hamnegard, C. H., Mills, G. H., Green, M., & Moxham, J. (1996) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199605)19:5<549::aid-mus1>3.0.co;2-b · Cited by 205
Niebauer, J., Pflaum, C.-D., Clark, A. L., Strasburger, C. J., Hooper, J., Poole-Wilson, P. A., Coats, A. J. S., & Anker, S. D. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00226-5 · Cited by 201
Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD
Vermeeren, M., Schols, A., & Wouters, E. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10102264 · Cited by 183
Dentener, M. A. (2001) · Thorax · doi:10.1136/thorax.56.9.721 · Cited by 165
Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease
Dev, D., Wallace, E., Sankaran, R., Cunniffe, J., Govan, J. R. W., Wathen, C. G., & Emmanuel, F. X. S. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90515-7 · Cited by 162
Hambrecht, R., Schulze, P. C., Gielen, S., Linke, A., Möbius‐Winkler, S., Yu, J., Kratzsch, J. Ü., Baldauf, G., Busse, M. W., Schubert, A., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01736-9 · Cited by 152
Rahman, I., Skwarska, E., & MacNee, W. (1997) · Thorax · doi:10.1136/thx.52.6.565 · Cited by 142
Creutzberg, E. C., Wouters, E. F. �., Augustin, I. M. L., Dentener, M. A., & Schols, A. M. W. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9912016 · Cited by 140
Tumour necrosis factor‐α increases the ubiquitinization of rat skeletal muscle proteins
Garcia‐Martínez, C., Agell, N., Llovera, M., López-Soriano, F. J., & Argilés, J. M. A. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81341-v · Cited by 139
Peripheral Muscle Weakness in Patients with Chronic Obstructive Pulmonary Disease.
Bernard, S., Leblanc, P., WHITTOM, F., Carrier, G., Jobin, J., Belleau, R., & Maltais, F. (1998) · Cardiopulmonary Physical Therapy Journal · doi:10.1097/01823246-199809040-00007 · Cited by 110
MARCELL, T. J., Harman, S. M., Urban, R. J., Metz, D. D., Rodgers, B. D., & Blackman, M. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1159 · Cited by 103
Ekberg‐Jansson, A., Andersson, B. A., Bake, B., Boijsen, M., ENANDEN, I., Rosengren, A., Skoogh, B., Tylén, U., Venge, P., & Löfdahl, C. G. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1050 · Cited by 102
Watchorn, T., Waddell, I. D., Dowidar, N., & Ross, J. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0534fje · Cited by 102
Cicoira, M., Bolger, A. P., Doehner, W., Rauchhaus, M., Davos, C. H., Sharma, R. K., Al-Nasser, F., Coats, A. J. S., & Anker, S. D. (2001) · Cytokine · doi:10.1006/cyto.2001.0918 · Cited by 87
Pharmacokinetics of Murine Tumor Necrosis Factor
Flick, D. A., & Glfford, G. E. (1986) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923978609031087 · Cited by 55
Peripheral Muscle Weakness Contributes to Exercise Limitation in COPD
Milani, R. V., Ries, A. L., & MYERS, J. N. (1996) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199611000-00015 · Cited by 45
Potential Novel Therapies for Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2000) · Novartis Foundation symposium · doi:10.1002/0470868678.ch16 · Cited by 26
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?
Willaert, W., Daenen, M., Bomans, P., Verleden, G. M., & Decramer, M. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00268702 · Cited by 25
Cited by
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationAmerican Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation
Nici, L., Donner, C., Wouters, E., Zuwallack, R., Ambrosino, N., Bourbeau, J., Carone, M., Celli, B., Engelen, M., Fahy, B., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1211st · Cited by 1,966
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
Maltais, F., Decramer, M., Casaburi, R., Barreiro, E., Burelle, Y., Debigaré, R., Dekhuijzen, P. N. R., Franssen, F., Gayan-Ramirez, G., Gea, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0373st · Cited by 1,090
Self-citation
Metadata
- Authors
- Spruit, M. A.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2003-09-01
- Volume
- 58
- Issue
- 9
- Pages
- 752-756
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2098705401
- Cited by
- 476
- References
- 48
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.